Keith Holley
Family · Hendersonville, TNNPI 1992483903
Payments from drug & device makers
Across 204 payments — averaging $20.28 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$693
- Novo Nordisk$557
- AstraZeneca$530
- Astellas Pharma US Inc$346
- GSK$257
- Pfizer$237
- plus $2K from 24 others
What the payments were for
- Food & beverage$4,137100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 31 | $693 |
| Novo Nordisk | 27 | $557 |
| AstraZeneca(2 entities) | 26 | $530 |
| Astellas Pharma US Inc | 17 | $346 |
| GSK | 12 | $257 |
| Pfizer | 13 | $237 |
| Lilly USA, LLC | 16 | $235 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 7 | $135 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 5 | $132 |
| Sumitomo Pharma America, Inc. | 8 | $129 |
| Otsuka America Pharmaceutical, Inc. | 5 | $121 |
| Exact Sciences | 6 | $97 |
| Phathom Pharmaceuticals, Inc. | 5 | $96 |
| Xeris Pharmaceuticals, Inc. | 4 | $82 |
| Antares Pharma, Inc. | 3 | $57 |
| Axsome Therapeutics, Inc. | 2 | $52 |
| Tolmar, Inc. | 3 | $48 |
| Bayer | 2 | $38 |
| Boston Scientific | 1 | $37 |
| Neurocrine Biosciences, Inc. | 1 | $33 |
| Vertex | 1 | $30 |
| Ascendis Pharma Endocrinology Inc | 1 | $28 |
| Hologic Sales And Service, LLC | 1 | $26 |
| Shield Therapeutics Inc | 1 | $22 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $22 |
| Seqirus USA Inc | 1 | $20 |
| Amgen | 1 | $20 |
| Dexcom, Inc. | 1 | $19 |
| Azurity Pharmaceuticals, Inc. | 1 | $19 |
| Amneal Pharmaceuticals LLC | 1 | $18 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$4,137 in reported general payments places this provider in the 85th percentile of 6,706 family providers in Tennessee.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 41 | $68,677 |
| FarxigaDapagliflozin Propanediol | 26 | $35,577 |
| TrulicityDulaglutide | 22 | $34,391 |
| XareltoRivaroxaban | 21 | $23,761 |
| EliquisApixaban | 19 | $23,482 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 11 | $20,345 |
| Serevent DiskusSalmeterol Xinafoate | 12 | $4,758 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 80 | $3,412 |
| PaxlovidNirmatrelvir/Ritonavir | 14 | $2,760 |
| Gabapentin | 159 | $2,413 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 22 | $2,399 |
| Atorvastatin Calcium | 181 | $1,943 |
| Pantoprazole Sodium | 106 | $1,641 |
| Ezetimibe | 44 | $1,557 |
| Tizanidine Hcl | 54 | $1,550 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic | $557 | $68,67741 claims |
| AstraZenecaFarxiga | $530 | $35,57726 claims |
| Lilly USA, LLCTrulicity | $235 | $34,39122 claims |
| PfizerEliquis, Paxlovid | $237 | $26,24333 claims |
| GSKTrelegy Ellipta | $257 | $20,34511 claims |
| Amneal Pharmaceuticals LLCLevothyroxine Sodium | $18 | $1,258133 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 6,706 family providers in Tennessee.
Other family in Hendersonville
- Stacy BrownMt Juliet$719K
- Dana WebberKnoxville$499K
- Brandy BiedermanHixson$448K
- Cynthia MillerMurfreesboro$384K
- Tamera ThoenerNashville$254K
- April SwonerHermitage$246K
- Jennifer WilliamsNashville$213K
- Chantil JeffreysGermantown$195K
- Laura PorchCordova$148K
- Lori LankfordNashville$148K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.